Viewing StudyNCT00024661



Ignite Creation Date: 2024-05-05 @ 11:23 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00024661
Status: COMPLETED
Last Update Posted: 2011-04-13
First Post: 2001-09-24

Brief Title: Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors
Sponsor: INSYS Therapeutics Inc
Organization: INSYS Therapeutics Inc

Organization Data

Organization: INSYS Therapeutics Inc
Class: INDUSTRY
Study ID: LErafAON-002
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: INSYS Therapeutics Inc
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Georgetown University OTHER